NEW YORK (GenomeWeb News) – Meridian Bioscience today said that revenues in its fiscal first quarter rose 13 percent year over year, led by its US Diagnostics unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.